Literature DB >> 23083532

The role of major vault protein (MVP) in drug resistance.

Kinam Park1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23083532     DOI： 10.1016/j.jconrel.2012.10.005

Source DB:  PubMed          Journal:  J Control Release        ISSN： 0168-3659            Impact factor:   9.776


× No keyword cloud information.
  8 in total

Review 1.  Small but Powerful: The Human Vault RNAs as Multifaceted Modulators of Pro-Survival Characteristics and Tumorigenesis.

Authors:  Stefano Gallo; EunBin Kong; Iolanda Ferro; Norbert Polacek
Journal:  Cancers (Basel)       Date:  2022-06-03       Impact factor: 6.575

2.  Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial-mesenchymal transition through targeting major vault protein (MVP).

Authors:  Lei Lou; Juan Wang; Fengzhu Lv; Guohui Wang; Yuehong Li; Lingxiao Xing; Haitao Shen; Xianghong Zhang
Journal:  Cell Oncol (Dordr)       Date:  2020-09-07       Impact factor: 6.730

3.  Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling.

Authors:  Jian-Shu Lou; Lu Yan; Cathy W C Bi; Gallant K L Chan; Qi-Yun Wu; Yun-Le Liu; Yun Huang; Ping Yao; Crystal Y Q Du; Tina T X Dong; Karl W K Tsim
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

4.  Modulation of the Vault Protein-Protein Interaction for Tuning of Molecular Release.

Authors:  Kang Yu; Yin Hoe Yau; Ameya Sinha; Tabitha Tan; Valerie A Kickhoefer; Leonard H Rome; Hwankyu Lee; Susana G Shochat; Sierin Lim
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

5.  The WT1/MVP-Mediated Stabilization on mTOR/AKT Axis Enhances the Effects of Cisplatin in Non-small Cell Lung Cancer by a Reformulated Yu Ping Feng San Herbal Preparation.

Authors:  Jian-Shu Lou; Yi-Teng Xia; Huai-You Wang; Xiang-Peng Kong; Ping Yao; Tina T X Dong; Zhong-Yu Zhou; Karl W K Tsim
Journal:  Front Pharmacol       Date:  2018-08-07       Impact factor: 5.810

6.  Major Vault Protein Inhibits Porcine Reproductive and Respiratory Syndrome Virus Infection in CRL2843CD163 Cell Lines and Primary Porcine Alveolar Macrophages.

Authors:  Xiaoping Wu; Junyang Fang; Qiuping Huang; Xu Chen; Zhongyi Guo; Lingyujia Tian; Enmin Zhou; Jianxin Chen; Yang Mu; Taofeng Du
Journal:  Viruses       Date:  2021-11-12       Impact factor: 5.048

7.  Major Vault Protein (MVP) Associated With BRAF V600E Mutation Is an Immune Microenvironment-Related Biomarker Promoting the Progression of Papillary Thyroid Cancer via MAPK/ERK and PI3K/AKT Pathways.

Authors:  Xubin Dong; Percy David Papa Akuetteh; Jingjing Song; Chao Ni; Cong Jin; Huihui Li; Wenjie Jiang; Yuhao Si; Xiaohua Zhang; Qiyu Zhang; Guanli Huang
Journal:  Front Cell Dev Biol       Date:  2022-03-31

8.  Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis.

Authors:  Daniela Lötsch; Elisabeth Steiner; Klaus Holzmann; Sabine Spiegl-Kreinecker; Christine Pirker; Juraj Hlavaty; Helga Petznek; Balazs Hegedus; Tamas Garay; Thomas Mohr; Wolfgang Sommergruber; Michael Grusch; Walter Berger
Journal:  Oncotarget       Date:  2013-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.